Trial Profile
Open label trial of aripiprazole in children and adolescents with Tourette's disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Gilles de la Tourette's syndrome
- Focus Therapeutic Use
- 22 Jul 2011 Status changed from recruiting to completed.
- 11 Dec 2006 New trial record.